| Date | Company Name | Action | Current
Price | Price
Target | Rating | Impact on
Share Price |
|---|
| 11/19/2024 | ACRS Aclaris Therapeutics | Upgrade | $4.00 | $2.00 ➝ $7.00 | Market Perform ➝ Outperform | N/A |
| 11/19/2024 | EHAB Enhabit | Reiterated Rating | $7.00 | $8.50 ➝ $8.00 | Market Perform ➝ Market Perform | N/A |
| 11/19/2024 | RCKT Rocket Pharmaceuticals | Lower Price Target | $13.00 | $46.00 ➝ $44.00 | Outperform ➝ Outperform | N/A |
| 11/19/2024 | ICLR ICON Public | Reiterated Rating | $204.00 | $270.00 ➝ $255.00 | Outperform ➝ Outperform | N/A |
| 11/19/2024 | IQV IQVIA | Reiterated Rating | $194.00 | $260.00 ➝ $248.00 | Outperform ➝ Outperform | N/A |
| 11/15/2024 | CMPX Compass Therapeutics | Downgrade | $1.00 | $5.00 ➝ $4.00 | Outperform ➝ Market Perform | N/A |
| 11/13/2024 | MASS 908 Devices | Reiterated Rating | $3.00 | $12.00 ➝ $4.00 | Outperform ➝ Market Perform | N/A |
| 11/13/2024 | LXEO Lexeo Therapeutics | Lower Price Target | $6.00 | $20.00 ➝ $19.00 | Outperform ➝ Outperform | N/A |
| 11/12/2024 | ARDT Ardent Health Partners | Boost Price Target | $16.00 | $23.00 ➝ $25.00 | Outperform ➝ Outperform | N/A |
| 11/12/2024 | NGNE Neurogene | Boost Price Target | $15.00 | $45.00 ➝ $72.00 | Outperform ➝ Outperform | N/A |
| 11/12/2024 | BMY Bristol-Myers Squibb | Upgrade | $58.00 | $55.00 ➝ $73.00 | Market Perform ➝ Outperform | N/A |
| 11/11/2024 | TECX Tectonic Therapeutic | Boost Price Target | $44.00 | $49.00 ➝ $69.00 | Outperform ➝ Outperform | N/A |
| 11/7/2024 | ZYME Zymeworks | Upgrade | $15.00 | $10.00 ➝ $25.00 | Market Perform ➝ Outperform | N/A |
| 11/7/2024 | XRAY DENTSPLY SIRONA | Downgrade | $19.00 | | Outperform ➝ Market Perform | N/A |
| 11/6/2024 | BEAM Beam Therapeutics | Upgrade | $24.00 | $27.00 ➝ $39.00 | Market Perform ➝ Outperform | N/A |
| 11/5/2024 | IDYA IDEAYA Biosciences | Downgrade | $26.00 | $41.00 ➝ $27.00 | Outperform ➝ Market Perform | Low |
| 11/4/2024 | ZURA Zura Bio | Initiated Coverage | $3.00 | $15.00 | Outperform | High |
| 10/31/2024 | NVST Envista | Upgrade | $20.00 | $16.00 ➝ $23.00 | Underperform ➝ Market Perform | High |
| 10/25/2024 | AQST Aquestive Therapeutics | Boost Price Target | $5.00 | $12.00 ➝ $13.00 | Outperform ➝ Outperform | Low |
| 10/25/2024 | DXCM DexCom | Lower Price Target | $75.00 | $90.00 ➝ $87.00 | Outperform ➝ Outperform | High |
| 10/25/2024 | ICLR ICON Public | Lower Price Target | $204.00 | $376.00 ➝ $270.00 | Outperform ➝ Outperform | High |
| 10/24/2024 | TENX Tenax Therapeutics | Initiated Coverage | $5.00 | $16.00 | Outperform | High |
| 10/21/2024 | GILD Gilead Sciences | Upgrade | $89.00 | $74.00 ➝ $96.00 | Market Perform ➝ Outperform | Low |
| 10/18/2024 | LXRX Lexicon Pharmaceuticals | Set Price Target | $1.00 | $6.00 | Outperform ➝ Outperform | Low |
| 10/18/2024 | TNYA Tenaya Therapeutics | Reiterated Rating | $2.00 | | Outperform ➝ Outperform | Low |
| 10/18/2024 | AMLX Amylyx Pharmaceuticals | Set Price Target | $5.00 | $4.00 | Market Perform ➝ Market Perform | High |
| 10/17/2024 | MASS 908 Devices | Lower Price Target | $3.00 | $15.00 ➝ $12.00 | Outperform ➝ Outperform | Medium |
| 10/17/2024 | GH Guardant Health | Lower Price Target | $31.00 | $60.00 ➝ $50.00 | Outperform ➝ Outperform | High |
| 10/17/2024 | BBIO BridgeBio Pharma | Lower Price Target | $23.00 | $47.00 ➝ $46.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | VCYT Veracyte | Boost Price Target | $39.00 | $35.00 ➝ $40.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | MIRM Mirum Pharmaceuticals | Boost Price Target | $44.00 | $47.00 ➝ $49.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | TWST Twist Bioscience | Boost Price Target | $41.00 | $45.00 ➝ $48.00 | Market Perform ➝ Market Perform | Medium |
| 10/17/2024 | RVTY Revvity | Boost Price Target | $111.00 | $130.00 ➝ $135.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | NTRA Natera | Boost Price Target | $168.00 | $140.00 ➝ $150.00 | Outperform ➝ Outperform | Medium |
| 10/17/2024 | ILMN Illumina | Boost Price Target | $132.00 | $160.00 ➝ $200.00 | Outperform ➝ Outperform | Low |
| 10/17/2024 | ISRG Intuitive Surgical | Boost Price Target | $542.00 | $489.00 ➝ $502.00 | | Low |
| 10/16/2024 | VYGR Voyager Therapeutics | Initiated Coverage | $5.00 | $15.00 | Outperform | High |
| 10/16/2024 | WVE Wave Life Sciences | Boost Price Target | $14.00 | $20.00 ➝ $22.00 | Outperform ➝ Outperform | High |
| 10/14/2024 | MNMD Mind Medicine (MindMed) | Initiated Coverage | $8.00 | $20.00 | Outperform | High |
| 10/14/2024 | STOK Stoke Therapeutics | Initiated Coverage | $11.00 | $18.00 | Outperform | High |
| 10/8/2024 | VINC Vincerx Pharma | Lower Price Target | $0.00 | $4.00 ➝ $2.00 | Outperform ➝ Outperform | High |
| 10/8/2024 | TVTX Travere Therapeutics | Reiterated Rating | $18.00 | $20.00 ➝ $20.00 | Outperform ➝ Outperform | Medium |
| 10/8/2024 | HOLX Hologic | Lower Price Target | $78.00 | $95.00 ➝ $90.00 | Outperform ➝ Outperform | Low |
| 10/7/2024 | COR Cencora | Lower Price Target | $243.00 | $277.00 ➝ $275.00 | Outperform ➝ Outperform | Low |
| 10/7/2024 | MCK McKesson | Lower Price Target | $621.00 | $665.00 ➝ $630.00 | Outperform ➝ Outperform | Low |
| 10/2/2024 | HUM Humana | Downgrade | $294.00 | $400.00 ➝ $250.00 | Outperform ➝ Market Perform | High |
| 9/30/2024 | AQST Aquestive Therapeutics | Reiterated Rating | $5.00 | $10.00 ➝ $12.00 | Outperform ➝ Outperform | High |
| 9/27/2024 | AGIO Agios Pharmaceuticals | Downgrade | $55.00 | $60.00 ➝ $56.00 | Outperform ➝ Market Perform | High |
| 9/24/2024 | REGN Regeneron Pharmaceuticals | Reiterated Rating | $743.00 | $1,175.00 ➝ $1,077.00 | Outperform ➝ Market Perform | High |
| 9/23/2024 | BHVN Biohaven | Boost Price Target | $47.00 | $55.00 ➝ $60.00 | Outperform ➝ Outperform | Low |
| 9/20/2024 | SPRY ARS Pharmaceuticals | Boost Price Target | $14.00 | $21.00 ➝ $25.00 | Outperform ➝ Outperform | Low |
| 9/19/2024 | APLT Applied Therapeutics | Boost Price Target | $9.00 | $11.00 ➝ $14.00 | Outperform ➝ Outperform | Low |
| 9/19/2024 | FDMT 4D Molecular Therapeutics | Reiterated Rating | $8.00 | $40.00 ➝ $36.00 | Outperform ➝ Outperform | High |
| 9/19/2024 | PGNY Progyny | Lower Price Target | $14.00 | $25.00 ➝ $21.00 | Market Perform ➝ Market Perform | High |
| 9/18/2024 | ICLR ICON Public | Initiated Coverage | $204.00 | $379.00 | Outperform | High |
| 9/17/2024 | ORKA Oruka Therapeutics | Initiated Coverage | $22.00 | $44.00 | Outperform | Low |
| 9/17/2024 | MRNA Moderna | Lower Price Target | $37.00 | $60.00 ➝ $48.00 | Underperform ➝ Underperform | Medium |
| 9/12/2024 | FULC Fulcrum Therapeutics | Reiterated Rating | $3.00 | $4.00 | Outperform ➝ Market Perform | N/A |
| 9/10/2024 | INSP Inspire Medical Systems | Boost Price Target | $185.00 | $167.00 ➝ $197.00 | Market Perform ➝ Market Perform | Low |
| 9/9/2024 | IMUX Immunic | Reiterated Rating | $1.00 | $5.00 | Outperform | Low |
| 9/9/2024 | TRVI Trevi Therapeutics | Initiated Coverage | $3.00 | $6.00 ➝ $7.00 | Outperform | High |
| 9/9/2024 | GERN Geron | Initiated Coverage | $4.00 | $7.00 | Outperform | Medium |
| 9/9/2024 | IRWD Ironwood Pharmaceuticals | Initiated Coverage | $4.00 | $5.00 | Market Perform | High |
| 9/9/2024 | MNKD MannKind | Initiated Coverage | $7.00 | $7.00 ➝ $8.00 | Outperform | Medium |
| 9/9/2024 | PLRX Pliant Therapeutics | Initiated Coverage | $13.00 | $46.00 ➝ $33.00 | Outperform | Low |
| 9/9/2024 | PRTC PureTech Health | Initiated Coverage | $22.00 | $58.00 ➝ $45.00 | Outperform | High |
| 9/9/2024 | GLPG Galapagos | Initiated Coverage | $26.00 | $24.00 | Market Perform | High |
| 9/9/2024 | KYMR Kymera Therapeutics | Reiterated Rating | $44.00 | $60.00 | Outperform | Medium |
| 9/5/2024 | MCK McKesson | Lower Price Target | $621.00 | $670.00 ➝ $665.00 | Outperform ➝ Outperform | Low |
| 9/3/2024 | RXRX Recursion Pharmaceuticals | Lower Price Target | $6.00 | $9.00 ➝ $8.00 | Market Perform ➝ Market Perform | Low |
| 9/3/2024 | TXG 10x Genomics | Initiated Coverage | $13.00 | $35.00 | Outperform | Low |
| 9/3/2024 | NARI Inari Medical | Initiated Coverage | $49.00 | $47.00 | Market Perform | Low |
| 9/3/2024 | PCVX Vaxcyte | Boost Price Target | $86.00 | $106.00 ➝ $153.00 | Outperform ➝ Outperform | Low |
| 9/3/2024 | PEN Penumbra | Initiated Coverage | $239.00 | $263.00 | Outperform | Low |
| 8/16/2024 | VIRX Viracta Therapeutics | Downgrade | $0.00 | $5.00 ➝ $3.00 | Outperform ➝ Market Perform | Low |
| 8/12/2024 | SPRY ARS Pharmaceuticals | Boost Price Target | $14.00 | $19.00 ➝ $20.00 | Outperform | Low |
| 8/12/2024 | ARDT Ardent Health Partners | Initiated Coverage | $16.00 | $23.00 | Outperform | Low |
| 8/12/2024 | ARCT Arcturus Therapeutics | Initiated Coverage | $16.00 | $70.00 | Outperform | Low |
| 8/7/2024 | PGNY Progyny | Downgrade | $14.00 | $31.00 ➝ $25.00 | Outperform ➝ Market Perform | Low |
| 8/6/2024 | TBPH Theravance Biopharma | Downgrade | $10.00 | $15.00 ➝ $10.00 | Outperform ➝ Market Perform | Low |
| 8/1/2024 | RCM R1 RCM | Downgrade | $14.00 | $17.00 ➝ $14.30 | Outperform ➝ Market Perform | Low |
| 8/1/2024 | WAT Waters | Upgrade | $358.00 | $325.00 ➝ $375.00 | Market Perform ➝ Outperform | Low |
| 7/24/2024 | TECX Tectonic Therapeutic | Initiated Coverage | $44.00 | $49.00 | Outperform | Low |
| 7/24/2024 | IONS Ionis Pharmaceuticals | Upgrade | $35.00 | $53.00 ➝ $62.00 | Market Perform ➝ Outperform | Low |
| 7/24/2024 | DHR Danaher | Boost Price Target | $233.00 | $275.00 ➝ $280.00 | Outperform | Low |
| 7/24/2024 | HCA HCA Healthcare | Boost Price Target | $333.00 | $367.00 ➝ $396.00 | Outperform ➝ Outperform | Low |
| 7/23/2024 | ALMS Alumis | Initiated Coverage | $10.00 | $29.00 | Outperform | Low |
| 7/22/2024 | BNTC Benitec Biopharma | Initiated Coverage | $11.00 | $13.00 | Outperform | Low |
| 7/22/2024 | CELC Celcuity | Initiated Coverage | $13.00 | $29.00 | Outperform | Low |
| 7/11/2024 | LNTH Lantheus | Boost Price Target | $86.00 | $106.00 ➝ $127.00 | Outperform ➝ Outperform | Low |
| 7/10/2024 | EHC Encompass Health | Initiated Coverage | $99.00 | $100.00 | Outperform | Low |
| 7/9/2024 | HLVX HilleVax | Downgrade | $2.00 | $28.00 ➝ $2.00 | Outperform ➝ Market Perform | Low |
| 7/8/2024 | RVTY Revvity | Initiated Coverage | $111.00 | $125.00 | Outperform | Low |
| 7/2/2024 | SDGR Schrödinger | Initiated Coverage | $19.00 | $29.00 | Outperform | Low |
| 6/27/2024 | COR Cencora | Reiterated Rating | $243.00 | $275.00 ➝ $275.00 | Outperform ➝ Outperform | Low |
| 6/25/2024 | ALNY Alnylam Pharmaceuticals | Boost Price Target | $249.00 | $138.00 ➝ $159.00 | Market Perform ➝ Market Perform | Low |
| 6/24/2024 | SLDB Solid Biosciences | Upgrade | $5.00 | $12.00 ➝ $12.00 | Market Perform ➝ Outperform | Low |
| 6/24/2024 | SRPT Sarepta Therapeutics | Boost Price Target | $111.00 | $165.00 ➝ $230.00 | Outperform ➝ Outperform | Low |
| 6/20/2024 | MREO Mereo BioPharma Group | Boost Price Target | $4.00 | $6.00 ➝ $8.00 | Outperform ➝ Outperform | Low |
| 5/21/2024 | QTTB Q32 Bio | Initiated Coverage | $27.00 | $54.00 | Outperform | Low |
